Account
Watchlists
Bookmarks
Pricing
Home
Dashboard
Ask Portfolio
Discovery
Timeline
ANTHEM
Q2 FY26
Anthem Biosciences: A Robust Q2 and H1 FY26 Driven by CRDMO and Strategic Expansions
Nov 13, 2025